Treace Medical Concepts
TMCI
127 hedge funds and large institutions have $264M invested in Treace Medical Concepts in 2024 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 55 increasing their positions, 25 reducing their positions, and 41 closing their positions.
120% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 25
5% less call options, than puts
Call options by funds: $2.93M | Put options by funds: $3.09M
10% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 41
2.83% less ownership
Funds ownership: 66.86% → 64.03% (-2.8%)
4% less funds holding
Funds holding: 132 → 127 (-5)
51% less capital invested
Capital invested by funds: $538M → $264M (-$274M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$23.9M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$10.9M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$8.24M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.33M |
| 5 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$6.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$30.1M |
| 2 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$20.4M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
-$18.1M |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$16M |
| 5 |
Millennium Management
New York
|
-$11M |
TMCI Hedge Fund Activity: Q2 2024 in Review
127 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q2 2024, worth a combined $264M — down 51% from $538M a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of TMCI and 37 opened new positions — a net loss of 4 holders — while 25 trimmed existing stakes and 55 added.
The largest buyer was Armistice Capital, adding an estimated $23.9M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $30.1M sold.
- 127 institutional investors held Treace Medical Concepts (TMCI) as of Q2 2024, down from 132 in Q1 2024.
- Funds reported $264M of Treace Medical Concepts stock for Q2 2024, down 51% quarter-over-quarter.
- 37 funds opened new Treace Medical Concepts positions in Q2 2024 and 41 closed out, a net change of -4 holders.
- The largest Treace Medical Concepts buyer in Q2 2024 was Armistice Capital, an estimated $23.9M added.
- The largest Treace Medical Concepts seller in Q2 2024 was Perceptive Advisors, an estimated $30.1M sold.
Based on aggregated 13F filings for Q2 2024.